Quality of life during the first 6 months of interferon-β treatment in patients with MS

To determine the quality of life (QoL) of MS patients during the initial 6 months of treatment with interferon-beta (IFN-beta). Furthermore, to determine whether changes in QoL relate to disability, emotional state, therapeutic expectations or side effect profile. IFN-beta has been shown to have ben...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Multiple sclerosis 2000-10, Vol.6 (5), p.338-342
Hauptverfasser:	ARNOLDUS, J. H. A, KILLESTEIN, J, PFENNINGS, Lema, JELLES, B, UITDEHAAG, B. M. J, POLMAN, C. H
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvants, Immunologic - administration & dosage Adjuvants, Immunologic - adverse effects b-Interferon Biological and medical sciences Emotions Follow-Up Studies Health Status Humans Immunomodulators Interferon beta-1a Interferon beta-1b Interferon-beta - administration & dosage Interferon-beta - adverse effects Longitudinal Studies Medical sciences Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Multiple Sclerosis, Relapsing-Remitting - drug therapy Multiple Sclerosis, Relapsing-Remitting - psychology Neurology Pharmacology. Drug treatments Quality of Life
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!